Morphological and electrophysiological changes in intratelencephalic-type pyramidal neurons in the motor cortex of a rat model of levodopa-induced dyskinesia

Neurobiology of Disease

Volumn 64, Issue , 2014, Pages 142-149

  Ueno, Tatsuya ^a,b   Yamada, Junko ^b   Nishijima, Haruo ^a,b   Arai, Akira ^a,b   Migita, Keisuke ^b   Baba, Masayuki ^a   Ueno, Shinya ^b   Tomiyama, Masahiko ^a,b  

^a AOMORI PREFECTURAL CENTRAL HOSPITAL   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

Author keywords

6 Hydroxydopamine; Animal model; Dyskinesia; Levodopa; Miniature excitatory postsynaptic currents; Motor cortex; Parkinson's disease; Plasticity; Spine; Whole cell patch clamp

Indexed keywords

LEVODOPA; OXIDOPAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN ELECTROPHYSIOLOGY; CELL DENSITY; CELL SIZE; CONTROLLED STUDY; DENDRITIC SPINE; DYSKINESIA; EXCITATORY POSTSYNAPTIC POTENTIAL; MALE; MORPHOLOGICAL TRAIT; MOTOR CORTEX; NERVE CELL PLASTICITY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; SENSITIVITY ANALYSIS; TRANSCRANIAL MAGNETIC STIMULATION; WHOLE CELL PATCH CLAMP;

6-HYDROXYDOPAMINE; ANIMAL MODEL; DYSKINESIA; LEVODOPA; MINIATURE EXCITATORY POSTSYNAPTIC CURRENTS; MOTOR CORTEX; PARKINSON'S DISEASE; PLASTICITY; SPINE; WHOLE-CELL PATCH CLAMP;

ANIMALS; ANTIPARKINSON AGENTS; DENDRITIC SPINES; DYSKINESIA, DRUG-INDUCED; EXCITATORY POSTSYNAPTIC POTENTIALS; LEVODOPA; MALE; MOTOR CORTEX; NEURAL PATHWAYS; OXIDOPAMINE; PARKINSONIAN DISORDERS; PYRAMIDAL CELLS; RATS; RATS, WISTAR; TELENCEPHALON;

EID: 84893026221     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2013.12.014     Document Type: Article

References (47)

1. Bagetta V., Sgobio C., Pendolino V., Del Papa G., Tozzi A., Ghiglieri V., Giampà C., Zianni E., Gardoni F., Calabresi P., Picconi B. Rebalance of striatal NMDA/AMPA receptor ratio underlies the reduced emergence of dyskinesia during D2-like dopamine agonist treatment in experimental Parkinson's disease. J. Neurosci. 2012, 32:17921-17931.
2. Ballion B., Mallet N., Bézard E., Lanciego J.L., Gonon F. Intratelencephalic corticostriatal neurons equally excite striatonigral and striatopallidal neurons and their discharge activity is selectively reduced in experimental Parkinsonism. Eur. J. Neurosci. 2008, 27:2313-2321.
3. Belujon P., Lodge D.J., Grace A.A. Aberrant striatal plasticity is specifically associated with dyskinesia following levodopa treatment. Mov. Disord. 2010, 25:1568-1576.
4. Bosch M., Hayashi Y. Structural plasticity of dendritic spines. Curr. Opin. Neurobiol. 2012, 22:383-388.
5. Buhl E.H., Schlote W. Intracellular lucifer yellow staining and electron microscopy of neurones in slices of fixed epitumourous human cortical tissue. Acta Neuropathol. 1987, 75:140-146.
6. Cenci M.A., Konradi C. Maladaptive striatal plasticity in l-DOPA-induced dyskinesia. Prog. Brain Res. 2010, 183:209-233.
7. Cenci M.A., Lundblad M. Ratings of l-DOPA-induced dyskinesia in the unilateral 6-OHDA lesion model of Parkinson's disease in rats and mice. Curr. Protoc. Neurosci. 2007, 9.25. 1-9.25.23.
8. Cenci M.A., Lee C.S., Björklund A. l-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA. Eur. J. Neurosci. 1998, 10:2694-2706.
9. Elston G.N., Rosa M.G. The occipitoparietal pathway of the macaque monkey: comparison of pyramidal cell morphology in layer III of functionally related cortical visual areas. Cereb. Cortex 1997, 7:432-452.
10. Elsworth J.D., Leranth C., Redmond D.E., Roth R.H. Loss of asymmetric spine synapses in prefrontal cortex of motor-asymptomatic, dopamine-depleted, cognitively impaired MPTP-treated monkeys. Int. J. Neuropsychopharmacol. 2013, 16:905-912.
11. Fabbrini G., Brotchie J.M., Grandas F., Nomoto M., Goetz C.G. Levodopa-induced dyskinesias. Mov. Disord. 2007, 22:1379-1389.
12. Feyder M., Bonito-Oliva A., Fisone G. l-DOPA-induced dyskinesia and abnormal signaling in striatal medium spiny neurons: focus on dopamine D1 receptor-mediated transmission. Front. Behav. Neurosci. 2011, 5:71.
13. Goldman-Rakic P.S., Leranth C., Williams S.M., Mons N., Geffard M. Dopamine synaptic complex with pyramidal neurons in primate cerebral cortex. Proc. Natl. Acad. Sci. U. S. A. 1989, 86:9015-9019.
14. Halje P., Tamtè M., Richter U., Mohammed M., Cenci M.A., Petersson P. Levodopa-induced dyskinesia is strongly associated with resonant cortical oscillations. J. Neurosci. 2012, 32:16541-16551.
15. Holtmaat A., Svoboda K. Experience-dependent structural synaptic plasticity in the mammalian brain. Nat. Rev. Neurosci. 2009, 10:647-658.
16. Hosp J.A., Pekanovic A., Rioult-Pedotti M.S., Luft A.R. Dopaminergic projections from midbrain to primary motor cortex mediate motor skill learning. J. Neurosci. 2011, 31:2481-2487.
17. Huang Y.Z., Rothwell J.C., Lu C.S., Chuang W.L., Chen R.S. Abnormal bidirectional plasticity-like effects in Parkinson's disease. Brain 2012, 134:2312-2320.
18. Kasai H., Fukuda M., Watanabe S., Hayashi-Takagi A., Noguchi J. Structural dynamics of dendritic spines in memory and cognition. Trends Neurosci. 2010, 33:121-129.
19. Kasai H., Hayama T., Ishikawa M., Watanabe S., Yagishita S., Noguchi J. Learning rules and persistence of dendritic spines. Eur. J. Neurosci. 2010, 32:241-249.
20. Kishore A., Popa T., Velayudhan B., Joseph T., Balachandran A., Meunier S. Acute dopamine boost has a negative effect on plasticity of the primary motor cortex in advanced Parkinson's disease. Brain 2012, 135:2074-2088.
21. Kress G.J., Yamawaki N., Wokosin D.L., Wickersham I.R., Shepherd G.M., Surmeier D.J. Convergent cortical innervation of striatal projection neurons. Nat. Neurosci. 2013, 16:665-667.
22. Lei W., Jiao Y., Del Mar N., Reiner A. Evidence for differential cortical input to direct pathway versus indirect pathway striatal projection neurons in rats. J. Neurosci. 2004, 24:8289-8299.
23. Luft A.R., Schwarz S. Dopaminergic signals in primary motor cortex. Int. J. Dev. Neurosci. 2009, 27:415-421.
24. Maeda T., Kannari K., Suda T., Matsunaga M. Loss of regulation by presynaptic dopamine D2 receptors of exogenous L-DOPA-derived dopamine release in the dopaminergic denervated striatum. Brain Res. 1999, 817:185-191.
25. Matsuzaki M., Ellis-Davies G.C., Nemoto T., Miyashita Y., Iino M., Kasai H. Dendritic spine geometry is critical for AMPA receptor expression in hippocampal CA1 pyramidal neurons. Nat. Neurosci. 2001, 4:1086-1092.
26. Matsuzaki M., Honkura N., Ellis-Davies G.C., Kasai H. Structural basis of long-term potentiation in single dendritic spines. Nature 2004, 429:761-766.
27. Miklyaeva E.I., Whishaw I.Q., Kolb B. A golgi analysis of cortical pyramidal cells in the unilateral Parkinson rat: absence of change in the affected hemisphere vs hypertrophy in the intact hemisphere. Restor. Neurol. Neurosci. 2007, 25:91-99.
28. Morgante F., Espay A.J., Gunraj C., Lang A.E., Chen R. Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias. Brain 2006, 129:1059-1069.
29. Murakoshi H., Yasuda R. Postsynaptic signaling during plasticity of dendritic spines. Trends Neurosci. 2012, 35:135-143.
30. Nandhu M.S., Paul J., Kuruvilla K.P., Malat A., Romeo C., Paulose C.S. Enhanced glutamate, IP3 and cAMP activity in the cerebral cortex of unilateral 6-hydroxydopamine induced Parkinson's rats: effect of 5-HT, GABA and bone marrow cell supplementation. J. Biomed. Sci. 2011, 18(1):5.
31. Navailles S., Bioulac B., Gross C., De.Deurwaerdère P. Serotonergic neurons mediate ectopic release of dopamine induced by L-DOPA in a rat model of Parkinson's disease. Neurobiol. Dis. 2010, 38:136-143.
32. Navailles S., Bioulac B., Gross C., De.Deurwaerdère P. Chronic L-DOPA therapy alters central serotonergic function and L-DOPA-induced dopamine release in a region-dependent manner in a rat model of Parkinson's disease. Neurobiol. Dis. 2011, 41:585-590.
33. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1998, Academic Press, San Diego, CA.
34. Picconi B., Centonze D., Håkansson K., Bernardi G., Greengard P., Fisone G., Cenci M.A., Calabresi P. Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia. Nat. Neurosci. 2003, 6:501-506.
35. Picconi B., Paillé V., Ghiglieri V., Bagetta V., Barone I., Lindgren H.S., Bernardi G., Angela Cenci M., Calabresi P. L-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation. Neurobiol. Dis. 2008, 29:327-335.
36. Picconi B., Bagetta V., Ghiglieri V., Paillè V., Di Filippo M., Pendolino V., Tozzi A., Giampà C., Fusco F.R., Sgobio C., Calabresi P. Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia. Brain 2011, 134:375-387.
37. Reiner A., Hart N.M., Lei W., Deng Y. Corticostriatal projection neurons - dichotomous types and dichotomous functions. Front. Neuroanat. 2010, 4:142.
38. Rothwell J. Transcranial magnetic stimulation as a method for investigating the plasticity of the brain in Parkinson's disease and dystonia. Parkinsonism Relat. Disord. 2007, 13:417-420.
39. Segal M. Dendritic spines, synaptic plasticity and neuronal survival: activity shapes dendritic spines to enhance neuronal viability. Eur. J. Neurosci. 2010, 31:2178-2184.
40. Stephens B., Mueller A.J., Shering A.F., Hood S.H., Taggart P., Arbuthnott G.W., Bell J.E., Kilford L., Kingsbury A.E., Daniel S.E., Ingham C.A. Evidence of a breakdown of corticostriatal connections in Parkinson's disease. Neuroscience 2005, 132:741-754.
41. Suppa A., Marsili L., Belvisi D., Conte A., Iezzi E., Modugno N., Fabbrini G., Berardelli A. Lack of LTP-like plasticity in primary motor cortex in Parkinson's disease. Exp. Neurol. 2011, 227:296-301.
42. Tanaka H., Kannari K., Maeda T., Tomiyama M., Suda T., Matsunaga M. Role of serotonergic neurons in L-DOPA-derived extracellular dopamine in the striatum of 6-OHDA-lesioned rats. Neuroreport 1999, 10:631-634.
43. Villalba R.M., Smith Y. Striatal spine plasticity in Parkinson's disease. Front. Neuroanat. 2010, 4:133.
44. Wall N.R., De.La.Parra M., Callaway E.M., Kreitzer A.C. Differential innervation of direct- and indirect-pathway striatal projection neurons. Neuron 2013, 79:347-360.
45. Wang H.D., Deutch A.Y. Dopamine depletion of the prefrontal cortex induces dendritic spine loss: reversal by atypical antipsychotic drug treatment. Neuropsychopharmacology 2008, 33:1276-1286.
46. Yamada J., Furukawa T., Ueno S., Yamamoto S., Fukuda A. Molecular basis for the GABAA receptor-mediated tonic inhibition in rat somatosensory cortex. Cereb. Cortex 2007, 17:1782-1787.
47. Zhou Q., Homma K.J., Poo M.M. Shrinkage of dendritic spines associated with long-term depression of hippocampal synapses. Neuron 2004, 44:749-757.